General Practice · Chestertown, MD
NPI
1295727063
Since 2005
Specialty
General Practice
Code 208D00000X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
6602 Church Hill Rd, Suite 500
Chestertown, MD, 21620
Phone (410) 778-6410
Groups this clinician bills Medicare through
Medicare paid, 2024
$190K
2,096 services
Medicare patients, 2024
407
Average age 75
Drug cost, 2024
$885K
12,573 prescriptions
Company payments, 2025
$340
From 11 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by John C Arrabal was code 99310 (snf e&m), 483 times for 84 patients. In total John C Arrabal billed 2,096 services in 33 codes, and Medicare paid $190K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2015-05-14.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99310 SNF E&M | Office | 483 | 84 | $112.91 | $55K |
| 99214 Office E&M - Established | Office | 438 | 215 | $82.89 | $36K |
| 99213 Office E&M - Established | Office | 335 | 183 | $55.03 | $18K |
| 99349 Home E&M - New and Established | Office | 267 | 40 | $90.10 | $24K |
| 99350 Home E&M - New and Established | Office | 159 | 32 | $132.67 | $21K |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 120 | 120 | $120.54 | $14K |
| 93000 Electrocardiogram | Office | 66 | 65 | $10.13 | $669 |
| 99306 SNF E&M | Office | 51 | 47 | $133.81 | $6,824 |
| 99215 Office E&M - Established | Office | 50 | 40 | $127.30 | $6,365 |
| 82270 Immunoassay | Office | 39 | 39 | $4.29 | $167 |
By year: 2022 $109K for 1,336 services; 2023 $162K for 1,748 services; 2024 $190K for 2,096 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 82270 Immunoassay | 39 | 39 | $4.29 | $167 |
Medicare prescription drug claims, 2024
In 2024, the drug John C Arrabal prescribed most often to Medicare patients was Atorvastatin Calcium, with 614 prescriptions and refills. In total John C Arrabal wrote 12,573 Medicare prescriptions that cost $885K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 614 | 1,067 | 128 | $10K |
| Amlodipine Besylate Generic | 501 | 1,017 | 116 | $4,162 |
| Pantoprazole Sodium Generic | 361 | 699 | 81 | $5,471 |
| Furosemide Generic | 351 | 610 | 89 | $1,950 |
| Quetiapine Fumarate Generic | 289 | 339 | 38 | $6,965 |
| Simvastatin Generic | 285 | 691 | 68 | $2,813 |
| Lisinopril Generic | 276 | 542 | 63 | $2,558 |
| Metoprolol Succinate Generic | 267 | 632 | 67 | $3,913 |
| Levothyroxine Sodium Generic | 259 | 435 | 50 | $3,347 |
| Donepezil Hcl Generic | 245 | 369 | 39 | $4,991 |
| Allopurinol Generic | 244 | 443 | 42 | $2,850 |
| Potassium Chloride Generic | 221 | 407 | 42 | $4,154 |
| Eliquis Apixaban | 219 | 253 | 35 | $131K |
| Losartan Potassium Generic | 213 | 479 | 48 | $2,376 |
| Gabapentin Generic | 206 | 267 | 50 | $3,505 |
Brand drugs: 1,297 claims; generic drugs: 11,239 claims; opioid claims: 71.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid John C Arrabal $340 ($340 in general payments such as food, travel and fees) from 11 companies. The largest payer was Exact Sciences Corporation with $55.89.
| Company | Payments | Amount |
|---|---|---|
| Exact Sciences Corporation EXAS | 3 | $55.89 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $43.5 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 2 | $37.6 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) JNJ | 2 | $36.22 |
| Lundbeck LLC | 1 | $31.81 |
| Astellas Pharma US Inc 4503.T | 1 | $28.74 |
| Radius Health, Inc. | 1 | $25.96 |
| Teva Pharmaceuticals USA, Inc. TEVA | 1 | $22.8 |
| AstraZeneca Pharmaceuticals LP AZN | 1 | $22 |
| Novo Nordisk Inc NVO | 1 | $17.89 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.